Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates.
about
Amine modification of nonporous silica nanoparticles reduces inflammatory response following intratracheal instillation in murine lungsSmart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriersIn Vivo Targeting of Metabolically Labeled Cancers with Ultra-Small Silica NanoconjugatesPolymeric Nanostructures for Imaging and TherapyPhotothermal optical lock-in optical coherence tomography for in vivo imagingIron oxide nanoparticles protected by NIR-active multidentate-polymers as multifunctional nanoprobes for NIRF/PA/MR trimodal imaging.Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticlesInvestigating the optimal size of anticancer nanomedicine.Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors.Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy.Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy.Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responsesProtein corona significantly reduces active targeting yield.Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates.Nonporous Silica Nanoparticles for Nanomedicine Application.Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers.Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacyPhotoswitchable nanoparticles for in vivo cancer chemotherapyEvaluation of doxorubicin-loaded 3-helix micelles as nanocarriers.Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials.Engineering synthetic vaccines using cues from natural immunity.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Smart chemistry in polymeric nanomedicine.Breakable mesoporous silica nanoparticles for targeted drug delivery.A facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment.Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells.Nanoparticles for combination drug therapy.Synthesis of paclitaxel-conjugated β-cyclodextrin polyrotaxane and its antitumor activity.In vitro evaluation of dendrimer-polymer hybrid nanoparticles on their controlled cellular targeting kinetics.Facilitating Translational Nanomedicine via Predictive Safety Assessment.Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencingPrecisely tunable engineering of sub-30 nm monodisperse oligonucleotide nanoparticlesAffinity-controlled protein encapsulation into sub-30 nm telodendrimer nanocarriers by multivalent and synergistic interactions.Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity.Redox-triggered activation of nanocarriers for mitochondria-targeting cancer chemotherapy.Inhibiting Solid Tumor Growth In Vivo by Non-Tumor-Penetrating Nanomedicine.Dual Stimuli-Responsive Poly(β-amino ester) Nanoparticles for On-Demand Burst Release.Subcellular-Scale Drug Transport via Ultrasound-Degradable Mesoporous Nanosilicon to Bypass Cancer Drug Resistance.Progress and challenges towards targeted delivery of cancer therapeutics.
P2860
Q28397622-1D9F54C5-4870-4BF5-95FE-F8AF7C723F4AQ28817755-F3AB25D3-AEAF-4973-A8DE-D515A9EF0C41Q28828629-09AEBA2A-C6F9-4036-9EB2-9B37045DE882Q30372383-5A8B197D-2498-4484-8923-5051CB80C554Q30408505-6D23F16C-5D31-4475-8F1F-31F938C608B3Q31031697-5913F7E2-4676-4150-A840-E82FB0879C03Q34145405-5F2EA2FF-10BE-4EEE-8F4A-F1FB8D448C11Q34442139-8C5EC1E0-CD9D-4C28-9A93-7A964E2953E0Q35800936-597D3451-937F-4EE2-8C9B-F05F16FF2077Q36820918-4B949EF7-F5C8-4470-808C-0EEEB6B922F4Q36821419-10853582-9517-4AC2-A8C0-C190C19BB9E4Q36872172-FB33AF17-8B1C-4143-AC2B-1C3E590103ACQ36899023-6C4AD4BE-76AD-4EC9-A467-28476EF7A67BQ36971700-E0E8AAA2-A591-4680-8AC0-62B7BD1D166CQ37131939-3198B64B-EA1A-45D0-9B6B-9921283F9847Q37179816-53A0E2F2-E2BB-44E1-B66A-FB96A777E57BQ37253857-A463FF1E-CC36-424D-ADA1-592E4FC29850Q37340860-98FEEADA-561B-484F-A426-DFA885250B97Q37581805-35863F5D-9987-49D6-9AB2-EDD1587BE083Q38075542-FE607550-4A6D-465C-91F2-B1C381928CBDQ38154804-105E1CDB-D379-476A-BFA6-3AA6DC3D3816Q38155457-474F2522-09B2-4836-9675-5349AEF6E5EAQ38221776-BE521E1A-CE85-4AD7-9122-EDBA3BE9AF0EQ38786580-7E9F6BBF-C172-48BA-ABFE-A923CE56D1DEQ38796959-16F6BD00-D7C8-4CE4-B521-F00D3B84DBF3Q38865261-9296F23F-EFA5-4A7F-B57B-46909FCCAC65Q39030019-3B647B1A-5471-41D4-B22B-F548769CA490Q39055298-0C27B193-9857-4919-81F6-EF1679A7BBF1Q39143472-EEF94110-BF0A-4C6E-A03B-6142B998373EQ39227278-154F22A9-74E7-4C93-826A-32DB67278CFBQ39244552-C8BD9177-CEB4-4F33-953D-A80F53F41B78Q39779323-0377C230-D82A-44DA-8BEE-0DD597A9C797Q41790614-8F575400-E7A5-45E4-92F1-3538AB14B888Q41809051-F0F73295-9A9C-472F-9430-00D0A9592DA4Q42109453-DE9C3909-0536-48B4-97CB-21BAC251AAD5Q48616806-A9316B19-A311-485A-98BE-5BBF1E7CE0A1Q48872676-F04A891E-D4EF-4AA0-8159-3E99766EC5C1Q50270905-F7CC040C-70A1-4DDD-B323-A7FA02DC1E30Q50664203-B6A65B63-8936-4584-8B17-BDD4A9450036Q52590993-384772DA-D2BB-4380-9E87-57D6577B0808
P2860
Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Synthesis and biological respo ...... se drug-silica nanoconjugates.
@ast
Synthesis and biological respo ...... se drug-silica nanoconjugates.
@en
type
label
Synthesis and biological respo ...... se drug-silica nanoconjugates.
@ast
Synthesis and biological respo ...... se drug-silica nanoconjugates.
@en
prefLabel
Synthesis and biological respo ...... se drug-silica nanoconjugates.
@ast
Synthesis and biological respo ...... se drug-silica nanoconjugates.
@en
P2860
P356
P1433
P1476
Synthesis and biological respo ...... rse drug-silica nanoconjugates
@en
P2093
Jianjun Cheng
Timothy M Fan
P2860
P304
P356
10.1021/NN300149C
P407
P577
2012-04-24T00:00:00Z